• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,423.80 1,423.80(%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,156.60 1,152.30(%)
  • Piramal Pharma
    235.45 235.45(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    190.80 227.00(%)
  • Swiggy
    183.05 174.30(%)
  • Cholaman.Inv.&Fn
    1,557.55 1,952.00(%)
  • Syngene Intl.
    418.75 678.00(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Patanjali Foods
    375.20 613.95(%)
  • Ola Electric
    37.44 51.84(%)
  • One 97
    1,640.50 1,856.50(%)
  • Acutaas Chemical
    3,686.00 1,571.20(%)
  • Sahajanand Medi
    462.10 347.50(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • FSN E-Commerce
    345.45 351.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mercury Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 2899.0
  • ISIN : INE947G01011
749.95 16 (2.16%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    731.00

  • Today’s High

    750.00

  • Open

    735.00

  • Perv Close

    734.10

  • 52W Low

    620.55

  • 52W High

    928.50

Key Indicators

  • P/E(TTM)

    20.50

  • Mar.Cap (₹Cr.)

    89.99

  • Div & Yield %

    0.47

  • Book Value(₹)

    483.97

  • Debt-Equity Ratio

    2.16

  • AGM Date

    27-Oct-2026

  • EPS

    36.59

  • P/E Ratio

    20.50

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    89.99

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    1.20

  • BV (₹)

    484.00

  • Sales( ₹ in Cr.)

    75.94

  • NP (in Cr.)

    5.13

  • NP Var(%)

    67.0

  • Div%

    35.0

  • CPS (₹)

    71.30

  • EPS (₹)

    42.80

  • Traded Value (₹ in Lakhs)

    89.99

  • 52 Week High

    928.50

  • 52 Week Low

    620.55

  • Price BSE

    750.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    89.99

  • P/C Ratio

    10.50

  • P/E Ratio

    17.50

  • Price Vs.BV

    42.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 75.94 75.10 75.56 75.33 57.92 68.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.94 75.10 75.56 75.33 57.92 68.60
Other Income 1.96 1.07 1.09 1.72 0.94 0.88
Stock Adjustments -1.89 0.74 0.15 0.55 0.22 -0.16
Total Income 76.01 76.91 76.80 77.60 59.08 69.32
EXPENDITURE :            
Raw Materials 27.20 29.20 30.02 30.96 23.88 31.01
Power and Fuel Cost 1.94 1.91 1.87 1.62 1.15 1.59
Employee Cost 17.44 16.84 14.50 14.24 12.50 9.80
Other Manufacturing Expenses 2.09 1.93 2.56 2.84 1.43 1.46
Selling and Administration Expenses 12.76 12.98 13.00 15.53 11.75 12.40
Miscellaneous Expenses 3.98 5.96 4.74 2.11 0.45 2.59
Employee Benefit Expenses 17.44 16.84 14.50 14.24 12.50 9.80
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 65.40 68.83 66.68 67.31 51.15 58.85
Operating Profit 10.60 8.09 10.12 10.29 7.94 10.47
Interest 0.54 0.55 0.38 0.36 0.45 0.64
Gross Profit 10.06 7.54 9.74 9.93 7.49 9.83
Depreciation 3.42 2.88 2.82 2.48 2.45 1.92
Profit Before Tax 6.64 4.66 6.92 7.45 5.04 7.91
Current Tax 1.66 1.35 1.90 2.20 1.37 2.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.14 0.17 -0.63 -0.34 0.10 0.39
Reported Net Profit 4.83 3.14 5.65 5.58 3.56 5.34
Extraordinary Items -0.30 0.07 0.05 -0.02 0.11 0.00
Adjusted Net Profit 5.13 3.07 5.60 5.60 3.45 5.34
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 8.66 5.93 4.20 2.54 2.72 1.50
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.42 0.42 3.92 3.92 3.74 3.92
P & L Balance carried down 13.07 8.66 5.93 4.20 2.54 2.92
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 35.00 35.00 35.00 35.00 35.00 35.00
Dividend Per Share(Rs) 3.50 3.50 3.50 3.50 3.50 3.50
Earnings Per Share-Unit Curr 40.28 26.21 47.12 46.49 29.68 44.48
Earnings Per Share(Adj)-Unit Curr 40.28 26.21 47.12 46.49 29.68 44.48
Book Value 483.97 446.41 423.65 380.24 335.89 307.45
Book Value(Adj)-Unit Curr 483.97 446.41 423.65 380.24 335.89 307.45

Shareholding Pattern

  • Promoter Group

    73.66%

  • Public Share Holding

    26.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 883,900 73.66 883,900 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 883,900 73.66 883,900 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 8,723 0.73 8,023 11
Clearing Members 675 0.06 675 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 24,747 2.06 13,547 23
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 6,333 0.53 6,133 35
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 26,390 2.20 26,390 1
Individuals holding nominal share capital up to Rs. 1 lakh 172,732 14.39 135,532 1,244
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 76,500 6.38 76,500 1
Sub Total 316,100 26.34 266,800 1,317
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 1,200,000 100.00 1,150,700 1,328

Company Background

Mercury Laboratories LtdPharmaceuticals - Indian - Formulations

  • Mercury Laboratories Ltd
  • BSE Code : 2899.0
  • ISIN : INE947G01011

  • Incorporation Year

    1982

  • Registered Office

    1st Floor 18 Shreeji Bhuwan 51
    Princess Street Mangaladas Rd, Mumbai,
    Maharashtra-400002

  • Telephone

    91-22-66372841

  • FAX

    91-22-22015441

  • Chairman

    SANJAY SHANTILAL PATEL

  • Managing Director

    Rajendra R Shah

  • Company Secretary

    Krishna Shah

  • Auditor

    Naresh & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    B-102&103 Shangrila,
    Complex First Floor,Akota
    Mumbai - Vadodara - 390 020

Mercury Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mercury Labs 749.95 77.89 75.94 21.61 11.32
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77